• Home/
  • News/
  • Give COVID-19 Vaccine Candidates Emergency Use Authorisation After Trials On Sufficient Sample Size: Parliamentary Panel

News

Give COVID-19 Vaccine Candidates Emergency Use Authorisation After Trials On Sufficient Sample Size: Parliamentary Panel

The report comes even as the government considers applications of at least three firms seeking emergency approval to roll out their vaccines against the coronavirus in India

Give COVID-19 Vaccine Candidates Emergency Use Authorisation After Trials On Sufficient Sample Size: Parliamentary Panel
Highlights
  • Parliamentary panel submitted its report on management of COVID-19 pandemic
  • Panel said emergency authorisation should be given in rarest of rare cases
  • Trials on small animals, human trials should be mandatorily undertaken: Pan

New Delhi: Any vaccine against COVID-19 should be granted emergency use authorisation only after proper consideration and conducting its trials on a sufficient sample size, a parliamentary panel chaired by senior Congress leader Anand Sharma has recommended to the government. In a report submitted Monday (December 21) to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.

Also Read: Vaccination For COVID-19 Will Be Voluntary, Advisable To Receive Complete Schedule Of Vaccine: Health Ministry

The report comes even as the government considers applications of at least three firms seeking emergency approval to roll out their vaccines against the coronavirus in India. The Centre last Tuesday (December 15) said the applications — by Bharat Biotech, Serum Institute of India and Pfizer — filed with the Drugs Controller General of India are being examined by the COVID-19 subject expert committee of Central Drugs Standard Control Organization (CDSCO).

The parliamentary committee report noted that the CDSCO has given no emergency use authorisation in the past, and suggested that all necessary and mandatory requirements must be duly fulfilled and all trial phases completed.

Also Read: Jammu And Kashmir’s Lieutenant Governor Launches ‘Electronic Vaccine Intelligence Network’ To Rationalise COVID-19 Vaccine Distribution

Trials on small animals, human trials should be mandatorily undertaken on a sufficient sample size population if at all emergency authorisation would be given, it should be given by Government with proper consideration and caution and this provision should be used in rarest of the rare cases, the report reads.

The report also noted that government hospitals bore the largest share of the burden of extending comprehensive healthcare during the pandemic, as private hospitals were either inaccessible or not affordable to everyone. Therefore, more fund should be allocated to public hospitals to strengthen the public health Infrastructure so that they can equip themselves appropriately to handle such pandemics in the future, the committee suggested in the report. It also recommended that learning from the experience of the pandemic, there is a need for a comprehensive public health act preferably at the national level with suitable legal provisions to support the government in keeping checks and controls over the private hospitals “as there have been reports about the selling of hospital beds by them”. “And also keep a check on the black marketing of medicines and product standardisation.”

Also Read: Global Partnership COVAX Secures Two Billion COVID-19 Vaccine Doses

At the same time, the panel said it is also necessary to make people aware through campaigns on cheaper and effective repurposed medicines to prevent them from panicking and spending a huge amount of money on expensive drugs.

The committee recommends that good quality and affordable medicines be provided to everyone, especially at a cheaper or subsidised rate to the marginalised sections of the society especially at the time of Pandemic like COVID-19, the report reads.

Also Read: National Expert Group On Vaccine Administration Working On Management Of COVID-19 Vaccine Roll-Out: Government

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

[corona_data_new]
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *